Citigroup bought a new position in shares of Edwards Lifesciences on August 5, 2026.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup bought a new position in shares of Edwards Lifesciences on August 5, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Edwards Lifesciences
American medical technology company
Related events
- Citigroup restated a buy rating on shares of Intensity Therapeutics.
- Citigroup reaffirmed a buy rating on BTI shares, and Capital Research Global Investors acquired shares of BTI.
- Citigroup reissued an outperform rating on American Integrity Insurance Group, Inc. shares.
- Citigroup and Royal Bank of Canada issued rating and price objective updates on shares of Brunello Cucinelli.
- Citigroup reiterated a buy rating on shares of Lifeward, which trades on the Nasdaq exchange.